<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799509</url>
  </required_header>
  <id_info>
    <org_study_id>VALIDATION</org_study_id>
    <nct_id>NCT04799509</nct_id>
  </id_info>
  <brief_title>Assessment of the 90-day Mortality Risk Score After VATS Lobectomy</brief_title>
  <official_title>Assessment of the 90-day Mortality Risk Score After Video-assisted Thoracoscopic Lobectomy in the Italian VATS Group Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted&#xD;
      thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3&#xD;
      points), carbon monoxide lung diffusion capacity &lt;60% (1 point) and operative time &gt;150&#xD;
      minutes (1 point), has been recently published. This study aims to assess the effectiveness&#xD;
      and reliability of this risk model in a large, independent cohort of patients, in order to&#xD;
      confirm its generalizability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From the Italian VATS Group Database, we selected patients who underwent video-assisted&#xD;
      thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk&#xD;
      score and the corresponding class of 90-day mortality risk for each patient. The correlation&#xD;
      between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration&#xD;
      was evaluated by Hosmer-Lemeshow goodness-of-fit test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">November 27, 2018</completion_date>
  <primary_completion_date type="Actual">November 27, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>90-day postoperative mortality</measure>
    <time_frame>90 day post surgical procedure</time_frame>
    <description>Alive/Death (cause of death)</description>
  </primary_outcome>
  <enrollment type="Actual">2209</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Surgery--Complications</condition>
  <condition>Morality</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS lobectomy</intervention_name>
    <description>VATS lobectomy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients were selected from the Italian VATS Group registry (a database containing&#xD;
        prospectively collected data on VATS anatomical lung resection performed in 58 certified&#xD;
        thoracic surgery centers from January 1st 2014). The VATS Group database was awarded by the&#xD;
        European Society of Thoracic Surgeons in the 2017&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patients undergoing VATS lobectomy for non-small cell lung cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Incomplete data for risk score calculation&#xD;
&#xD;
          -  Tumor size &gt;5 cm&#xD;
&#xD;
          -  Follow-up &lt;3 months&#xD;
&#xD;
          -  Patients undergoing neoadjuvant treatment&#xD;
&#xD;
          -  Patients undergoing extended resection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Imperatori, MD</last_name>
    <role>Study Director</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <reference>
    <citation>Brunelli A, Dinesh P, Woodcock-Shaw J, Littlechild D, Pompili C. Ninety-Day Mortality After Video-Assisted Thoracoscopic Lobectomy: Incidence and Risk Factors. Ann Thorac Surg. 2017 Sep;104(3):1020-1026. doi: 10.1016/j.athoracsur.2017.02.083. Epub 2017 Jun 1.</citation>
    <PMID>28577845</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 12, 2021</study_first_submitted>
  <study_first_submitted_qc>March 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Maria Cattoni</investigator_full_name>
    <investigator_title>Principal Investigator - Clinician at Center for Thoracic Surgery - School of Medicine and Surgery - University of Insubria - Varese</investigator_title>
  </responsible_party>
  <keyword>non-small cell lung cancer</keyword>
  <keyword>VATS lobectomy</keyword>
  <keyword>90-day postoperative mortality</keyword>
  <keyword>risk score</keyword>
  <keyword>validation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

